Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Quanterix Corporation - Common Stock
(NQ:
QTRX
)
7.080
-0.140 (-1.94%)
Streaming Delayed Price
Updated: 9:40 AM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quanterix Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Quanterix Corporation (QTRX) on Behalf of Investors
November 13, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Quanterix Corporation (QTRX) on Behalf of Investors
November 13, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
November 12, 2024
From
Quanterix
Via
Business Wire
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
What's Next: Quanterix's Earnings Preview
↗
November 11, 2024
Via
Benzinga
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
March 01, 2024
Via
Investor Brand Network
Earnings Scheduled For February 29, 2024
↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
November 05, 2024
From
Quanterix Corporation
Via
Business Wire
New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information
October 28, 2024
From
Quanterix
Via
Business Wire
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
October 02, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces Commercialization of p-Tau 217 Test Kit
September 30, 2024
From
Quanterix Corporation
Via
Business Wire
Earnings Preview: Quanterix
↗
February 28, 2024
Via
Benzinga
Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
Quanterix Corporation
Via
Business Wire
Jeffrey Elliott Appointed to Quanterix’s Board of Directors
August 19, 2024
From
Quanterix Corporation
Via
Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
QTRX stock results show that Quanterix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For February 27, 2024
↗
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Quanterix Releases Financial Results for the Second Quarter of 2024
August 08, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix To Report Second Quarter 2024 Financial Results
July 31, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
July 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
June 17, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
June 05, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
May 22, 2024
From
Quanterix Corporation
Via
Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024
↗
May 07, 2024
QTRX stock results show that Quanterix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Quanterix Releases Financial Results for the First Quarter of 2024
May 07, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix To Report First Quarter 2024 Financial Results
April 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
March 21, 2024
From
Quanterix
Via
Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
March 04, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
February 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
